QJP: Catheter, Percutaneous, Neurovasculature
What it covers
To provide vascular access to the neurovasculature for interventional or diagnostic procedures
FDA’s definition of product code QJP, from the Product Classification database.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K261649 | Excelsior Reach Microcatheter | Stryker Neurovascular | Oct 9, 2026 | Traditional |
| K261938 | APRO 88 Catheter | Alembic, LLC | Oct 6, 2026 | Traditional |
| K253422 | OAB Delivery Catheter | Cognition Medical Corp. | Oct 2, 2026 | Traditional |
| K260220 | Route 92 Medical Full Length 046 Access System | Route 92 Medical, Inc. | Sep 16, 2026 | Traditional |
| K262277 | 70 NeuGlide Catheter | Piraeus Medical, Inc. | Sep 4, 2026 | Special |
| K261176 | Zoom 4S Catheter | Imperative Care, Inc. | Aug 28, 2026 | Traditional |
| K254071 | p17 XR Microcatheter | Wallaby Medical | Aug 18, 2026 | Traditional |
| K260199 | SLIM Microcatheter | Balt USA, LLC | Jul 13, 2026 | Traditional |
| K253901 | Millipede88 Access Catheter | Perfuze, Ltd. | Jul 9, 2026 | Traditional |
| K261889 | Trevo Trak 21 Microcatheter | Stryker Neurovascular | Jul 1, 2026 | Special |
Clearances by year
103 QJP 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 22 | 141 |
| 2025 | 14 | 116 |
| 2024 | 18 | 188 |
| 2023 | 14 | 184 |
| 2022 | 14 | 206 |
| 2021 | 12 | 139 |
| 2020 | 9 | 72 |
Who submits
45 applicants cleared a QJP device since 2011. 78% of the clearances went to applicants in United States, then Ireland (7%), Japan (7%) and China (6%). By type: Traditional 69% and Special 31%. 4 went through a third-party review organization.
| Applicant | Clearances since 2011 |
|---|---|
| Stryker Neurovascular | 10 |
| Route 92 Medical, Inc. | 7 |
| Asahi Intecc Co., Ltd. | 6 |
| Balt USA, LLC | 6 |
| Imperative Care, Inc. | 6 |
| Penumbra, Inc. | 5 |
| Perfuze, Ltd. | 5 |
| Cerenovus, Inc. | 4 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 870.1250.
Standards
21 CFR 870.1250 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent QJP clearances declared.
Ask about QJP
Questions about QJP
What is FDA product code QJP?
Product code QJP, “Catheter, Percutaneous, Neurovasculature” in FDA's classification database, is a Class II device type under 21 CFR 870.1250 (percutaneous catheter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 103 clearances under QJP, 103 of them since 2011.
How many 510(k) clearances are there under QJP?
FDA’s 510(k) database listed 103 clearances under QJP as of Oct 29, 2026, 103 of them decided since 2011; the most recent decision was Oct 9, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a QJP 510(k)?
For the 43 QJP clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 143 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most QJP clearances?
Since 2011: Stryker Neurovascular (10), Route 92 Medical, Inc. (7), Asahi Intecc Co., Ltd. (6), Balt USA, LLC (6) and Imperative Care, Inc. (6). 45 applicants have cleared a QJP device in that time.